Giuseppe Danilo Di Stasio - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Cancers|July 24, 2021

From the Magic Bullet to Theragnostics: Certitudes and Hypotheses, Trying to Optimize the Somatostatin ModelGiuseppe Danilo Di Stasio, Pasqualina Buonomano, Laura Lavinia Travaini, et al.

Diagnostics (Basel, Switzerland)|June 2, 2021

The Role of Molecular Imaging in a Muscle-Invasive Bladder Cancer Patient: A Narrative Review in the Era of Multimodality TreatmentVincenzo Cuccurullo, Giuseppe Danilo Di Stasio, Francesco Manti, et al.

Endocrine|February 7, 2024

Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysisManila Rubino, Giuseppe Danilo Di Stasio, Lisa Bodei, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Cancers|July 24, 2021

From the Magic Bullet to Theragnostics: Certitudes and Hypotheses, Trying to Optimize the Somatostatin ModelGiuseppe Danilo Di Stasio, Pasqualina Buonomano, Laura Lavinia Travaini, et al.

Diagnostics (Basel, Switzerland)|June 2, 2021

The Role of Molecular Imaging in a Muscle-Invasive Bladder Cancer Patient: A Narrative Review in the Era of Multimodality TreatmentVincenzo Cuccurullo, Giuseppe Danilo Di Stasio, Francesco Manti, et al.

Endocrine|February 7, 2024

Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysisManila Rubino, Giuseppe Danilo Di Stasio, Lisa Bodei, et al.

Pageof 2